WO1999006561A3 - Chemokine receptor ccr8 dna and uses thereof - Google Patents

Chemokine receptor ccr8 dna and uses thereof Download PDF

Info

Publication number
WO1999006561A3
WO1999006561A3 PCT/US1998/015730 US9815730W WO9906561A3 WO 1999006561 A3 WO1999006561 A3 WO 1999006561A3 US 9815730 W US9815730 W US 9815730W WO 9906561 A3 WO9906561 A3 WO 9906561A3
Authority
WO
WIPO (PCT)
Prior art keywords
ccr8
hiv
infection
human
chemokine receptor
Prior art date
Application number
PCT/US1998/015730
Other languages
French (fr)
Other versions
WO1999006561A2 (en
Inventor
H Lee Tiffany
Philip M Murphy
Edward A Berger
Ghalib Alkhatib
Hernan Bazan
Tom I Bonner
Laura Lautens
Original Assignee
Us Health
H Lee Tiffany
Philip M Murphy
Edward A Berger
Ghalib Alkhatib
Hernan Bazan
Tom I Bonner
Laura Lautens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health, H Lee Tiffany, Philip M Murphy, Edward A Berger, Ghalib Alkhatib, Hernan Bazan, Tom I Bonner, Laura Lautens filed Critical Us Health
Priority to AU86695/98A priority Critical patent/AU8669598A/en
Publication of WO1999006561A2 publication Critical patent/WO1999006561A2/en
Publication of WO1999006561A3 publication Critical patent/WO1999006561A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The susceptibility of target to human immunodeficiency virus (HIV) infection depends on cell surface expression of the human CD4 molecule and CC chemokine receptor 8. CCR8 is a member of the 7-transmembrane segment superfamily of G-protein-coupled cell surface molecules. CCR8 plays an essential role in the membrane fusion step of infection by diverse HIV isolates. The establishment of stable, nonhuman cell lines and transgenic mammals having cells that coexpress human CD4 and CCR8 provides valuable tools for the continuing research of HIV infection. In addition, antibodies which bind to CCR8, CCR8 variants, and CCR8-binding agents, capable of blocking membrane fusion between HIV and target cells represent potential anti-HIV therapeutics.
PCT/US1998/015730 1997-07-29 1998-07-29 Chemokine receptor ccr8 dna and uses thereof WO1999006561A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU86695/98A AU8669598A (en) 1997-07-29 1998-07-29 Chemokine receptor ccr8 dna and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5409497P 1997-07-29 1997-07-29
US60/054,094 1997-07-29

Publications (2)

Publication Number Publication Date
WO1999006561A2 WO1999006561A2 (en) 1999-02-11
WO1999006561A3 true WO1999006561A3 (en) 1999-04-22

Family

ID=21988764

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/015730 WO1999006561A2 (en) 1997-07-29 1998-07-29 Chemokine receptor ccr8 dna and uses thereof

Country Status (2)

Country Link
AU (1) AU8669598A (en)
WO (1) WO1999006561A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
FR2771423A1 (en) * 1997-11-21 1999-05-28 Transgene Sa Recombinant viral vector expressing polypeptide that inhibits viral binding
WO2001058484A2 (en) * 2000-02-10 2001-08-16 Schering Corporation Novel uses of mammalian ccr8 receptors and related reagents
US6762341B2 (en) 2000-02-10 2004-07-13 Schering Corporation Uses of mammalian CCR8 receptors and related reagents
WO2002022651A2 (en) * 2000-09-15 2002-03-21 Genaissance Pharmaceuticals, Inc. Haplotypes of the ccr8 gene
EP1432801A2 (en) * 2001-02-06 2004-06-30 Incyte Genomics, Inc. Receptors and membrane-associated proteins
AU2003229753A1 (en) * 2002-05-13 2003-11-11 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)
WO2007044756A2 (en) * 2005-10-11 2007-04-19 Icos Corporation Monoclonal antibodies recognizing human ccr8
CA3023980A1 (en) * 2016-05-16 2017-11-23 Checkmab S.R.L. Markers selectively deregulated in tumor-infiltrating regulatory t cells
BR112021011431A2 (en) * 2018-12-27 2021-11-23 Univ Osaka Monoclonal antibody or an antibody fragment thereof that binds to ccr8, its use, as well as pharmaceutical composition, polynucleotide, expression vector and kit
EP3935151A1 (en) 2019-03-08 2022-01-12 Klinikum der Universität München Ccr8 expressing lymphocytes for targeted tumor therapy
JP2023546121A (en) * 2020-10-16 2023-11-01 ラノバ メディシンズ リミテッド Anti-CCR8 monoclonal antibody and its use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039434A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Human g-protein receptor hgber32

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039434A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Human g-protein receptor hgber32

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BERNARDINI, G. ET AL.: "Identification of the CC chemokines TARC and macrophage inflammatory protein-1 beta as novel functional ligands for the CCR8 receptor", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 28, no. 2, February 1998 (1998-02-01), pages 582 - 588, XP002092743 *
HORUK, R. ET AL.: "The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains", JOURNAL OF BIOLOGICAL CHEMISTRY. (MICROFILMS), vol. 273, no. 1, 2 January 1998 (1998-01-02), MD US, pages 386 - 391, XP002092742 *
ROOS, R. STUBER ET AL.: "Identification of CCR8, the receptor for the human CC Chemokine I-309", JOURNAL OF BIOLOGICAL CHEMISTRY (MICROFILMS), vol. 272, no. 28, 11 July 1997 (1997-07-11), MD US, pages 17251 - 17257, XP002092741 *
RUCKER, J. ET AL.: "Utilization of chemokine receptors, orphan receptors, and Herpesvirus-encoded receptors by diverse Human and Simian Immunodeficiency Viruses", JOURNAL OF VIROLOGY., vol. 71, no. 12, December 1997 (1997-12-01), ICAN SOCIETY FOR MICROBIOLOGY US, pages 8999 - 9007, XP002092744 *
SAMSON, M. ET AL.: "Molecular cloning and chromosomal mapping of a novel human gene, ChemR1, expressed in T lymphocytes and polymorphonuclear cells and encoding a putative chemokine receptor", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 26, 1996, pages 3021 - 3028, XP002092740 *
TIFFANY, H. L. ET AL.: "A model system for inducible expression of the CC chemokine receptors CCR1, CCR3 and CCR8", JOURNAL OF LEUKOCYTE BIOLOGY, no. suppl, December 1997 (1997-12-01), pages 7, XP002092745 *
TIFFANY, H. L. ET AL.: "Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309", JOURNAL OF EXPERIMENTAL MEDICINE, vol. 186, no. 1, 7 July 1997 (1997-07-07), pages 165 - 170, XP002092538 *
ZABALLOS A ET AL: "MOLECULAR CLONING AND RNA EXPRESSION OF TWO NEW HUMAN CHEMOKINE RECEPTOR-LIKE GENES", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 227, no. 3, 23 October 1996 (1996-10-23), pages 846 - 853, XP002055490 *

Also Published As

Publication number Publication date
WO1999006561A2 (en) 1999-02-11
AU8669598A (en) 1999-02-22

Similar Documents

Publication Publication Date Title
WO1997045543A3 (en) Cc chemokine receptor 5, antibodies thereto, transgenic animals
WO1999006561A3 (en) Chemokine receptor ccr8 dna and uses thereof
DE69029036D1 (en) SPECIFIC REAGENTS FOR AIDS THERAPY
Sweet et al. CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological target
CA2107732A1 (en) Retrovirus from the hiv group and its use
WO1998018826A3 (en) Anti-CCR5 antibodies and methods of use therefor
Yang et al. Enhanced inhibition of human immunodeficiency virus type 1 by Met-stromal-derived factor 1β correlates with down-modulation of CXCR4
WO2001043779A3 (en) Anti-hiv-1 conjugates for treatment of hiv disease
CA2140538A1 (en) Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
AU3401289A (en) Endowing cells with antibody specificity
AU4712397A (en) Lentiviral vectors
WO2003089624A3 (en) Fc receptor homolog, reagents, and uses thereof
CA2209301A1 (en) Redirection of cellular immunity by protein-tyrosine kinase chimeras
CA2069960A1 (en) Bispecific heteroantibodies with dual effector functions
Yuan et al. CD4-induced T-20 binding to human immunodeficiency virus type 1 gp120 blocks interaction with the CXCR4 coreceptor
WO2003016333A3 (en) Virus coat protein/receptor chimeras and methods of use
WO1998009642A3 (en) Therapeutic chemokine antagonists
Tsoukas et al. The role of the T3 molecular complex in antigen recognition and subsequent activation events
ATE335835T1 (en) ANTIBODIES AGAINST A COMPLEX OF CD4 AND A CHEMOKINE RECEPTOR DOMAIN, AND THEIR USE AGAINST HIV INFECTIONS
WO2002068654A3 (en) Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
REDDY et al. Elevated soluble interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations
Morikawa et al. Reduction in CD4 binding affinity associated with removal of a single glycosylation site in the external glycoprotein of HIV-2
Guillon et al. Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interaction
WO1998044098A3 (en) Strl33, a human fusion accessory factor associated with hiv infection
Douvas et al. Cross-Reactivity between Autoimmune Anti-Ul snRNP Antibodies and Neutralizing Epitopes of HIV-1 gp 120/41

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA